it is primarily used in the treatment of schizophrenia and bipolar disorder other uses include as an add on treatment in major depressive disorder tic disorders and irritability associated with autism it is taken by mouth or injection into a muscle a cochrane review found only low quality evidence of effectiveness in treating schizophrenia additionally since many people dropped out of the studies before they were completed the strength of the conclusions was low common side effects include vomiting constipation sleepiness dizziness weight gain and movement disorders serious side effects may include neuroleptic malignant syndrome tardive dyskinesia and anaphylaxis it is not recommended for older people with dementia related psychosis due to an increased risk of death in pregnancy there is evidence of possible harm to the baby it is not recommended in women who are breastfeeding it has not been very well studied in people less than 18 years old the exact mode of action is not entirely clear but may involve effects on dopamine and serotonin aripiprazole was approved for medical use in the united states in 2002 it is available as a generic medication in the united kingdom a month s supply costs the nhs about 2